Advertisement

Update 1991 pp 444-453 | Cite as

Continuous Renal Replacement Therapy

  • S. K. Wedel
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 14)

Abstract

Continous renal replacement therapies are advantageous alternatives to traditional modes of dialysis. In many critically ill patients, they have become the extracorporeal treatment of choice for fluid and solute removal. This chapter will describe two continuous renal replacement therapies, continuous arteriovenous hemofiltration (CAVH) and continuous arteriovenous hemodialysis (CAVHD), and their technical and operational characteristics.

Keywords

Continuous Renal Replacement Therapy Blood Pump Oncotic Pressure Plasma Water Ultrafiltration Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kramer P, Wigger W, Rieger J, et al. (1977) Arteriovenous hemofiltration: A new and simple method for treatment of overhydrated patients resistant to diuretics. Clin Wochenschr 55:1121–1122CrossRefGoogle Scholar
  2. 2.
    Geronemus R, Schneider N (1984) Continuous arteriovenous hemodialysis: A new modality for treatment of acute renal failure. Trans Am Soc Artif Intern Organs 30:610–612PubMedGoogle Scholar
  3. 3.
    Sigler MH, Teehan BP (1987) Solute transport in continuous hemodialysis: A new treatment for acute renal failure. Kidney Int 32:562–571PubMedCrossRefGoogle Scholar
  4. 4.
    Schuenemann B, Borghardt J, Falda Z, et al. (1987) Reactions of anuric intensive care patients with arteriovenous hemofiltration. Int J Artif Intern Organs 24:687–689Google Scholar
  5. 5.
    Bohler J, Kramer P, Goltze O, et al. (1983) Leukocyte counts and complement activation during pumpdriven and arteriovenous hemofiltration. Contrib Nephrol 36:15–25PubMedGoogle Scholar
  6. 6.
    Jacob AI, Gravellas G, Zarco R, et al. (1980) Leukopenia hypoxia and complement function with different hemodialysis membranes. Kidney Int 18:505–509PubMedCrossRefGoogle Scholar
  7. 7.
    Kaplan A, Longnecker RE, Folkert VW (1984) Continuous arteriovenous hemofiltration. Ann Intern Med 100:358–367PubMedGoogle Scholar
  8. 8.
    Gotloib L, Barzilay E, Shustak A, et al. (1986) Hemofiltration in septic ARDS: The artificial kidney as an artificial endocrine lung. Resuscitation 13:123–132PubMedCrossRefGoogle Scholar
  9. 9.
    Ossenkoppele GJ, van der Meulen J, Bronsveld W, et al. (1985) Continuous arteriovenous Hemofiltration as an adjunctive therapy for septic shock. Crit Care Med 13:102–104PubMedCrossRefGoogle Scholar
  10. 10.
    Coraim FJ, Coraim HP, Ebermann R, et al. (1986) Acute respiratory failure after cardiac surgery: Clinical experience with the application of continuous arteriovenous hemofiltration. Crit Care Med 14:714–718PubMedCrossRefGoogle Scholar
  11. 11.
    Wedel S (1989) Continous arteriovenous Hemofiltration and continuous arteriovenous hemodialysis. Probl Anesth 3:245–257Google Scholar
  12. 12.
    Rimondini A, Dipolli CM, Bella PD, et al. (1987) Hemofiltration as short-term treatment for refractory congestive heart failure. Am J Med 83:43–48PubMedCrossRefGoogle Scholar
  13. 13.
    Pacher R, Frass M, Hartter E, et al. (1986) Continuous pump-driven Hemofiltration associated with a decline in alpha-atrial natriuretic peptide. Crit Care Med 14:1010–1014PubMedCrossRefGoogle Scholar
  14. 14.
    Susini G, Zucchetti M, Bortone F, et al. (1990) Isolated ultrafiltration in cardiogenic pulmonary edema. Crit Care Med 18:14–17PubMedCrossRefGoogle Scholar
  15. 15.
    DiCarlo JV, Dudley TE, Sherbotie JR, et al. (1990) Continuous arteriovenous hemofiltration/dialysis improves pulmonary gas exchange in children with multiple organ system failure. Crit Care Med 18:822–826PubMedCrossRefGoogle Scholar
  16. 16.
    Barzilay E, Kessler D, Berlot G, et al. (1989) Use of extracorporeal supportive techniques as additional treatment for septic induced multiple organ failure patients. Crit Care Med 17:634–637PubMedCrossRefGoogle Scholar
  17. 17.
    Bartlett RH, Mault Jr, Dechert RE, et al. (1986) Continuous arteriovenous hemofiltration: Improved survival in surgical acute renal failure? Surgery 100:400–408PubMedGoogle Scholar
  18. 18.
    Golper TA (1985) Continuous arteriovenous hemofiltration in acute renal failure. Am J Kidney Dis 6:373–386PubMedGoogle Scholar
  19. 19.
    Golper TA, Wedel SK, Kaplan AA, et al. (1985) Drug removal during continuous arteriovenous hemofiltration: Theory and clinical observations. Int J Artif Organs 8:307–312PubMedGoogle Scholar
  20. 20.
    Bennett WM, Aronoff GR, Morrison G, et al. (1983) Drug prescribing in renal failure: Dosing guidelines for adults. Am J Kidney Dis 3:155–193PubMedGoogle Scholar
  21. 21.
    Bickley SK (1988) Drug dosing during continuous arteriovenous hemofiltration. Clinical Pharmacy 7:198–206PubMedGoogle Scholar
  22. 22.
    Leone MR, Jenkins RD, Golper TA, et al. (1986) Early experience with continuous arteriovenous hemofiltration in critically ill pediatric patients. Crit Care Med 14:1058–1064PubMedCrossRefGoogle Scholar
  23. 23.
    Zobel G, Ring E, Muller W (1989) Continuous arteriovenous hemofiltration in premature infants. Crit Care Med 17:534–536PubMedCrossRefGoogle Scholar
  24. 24.
    Golper TA, Bennett WM (1988) Drug removal by continuous arteriovenous haemofiltration. A review of the evidence in poisoned patients. Med Toxical Adverse Drug Exp 3(5):341–349Google Scholar
  25. 25.
    Domoto DT, Brown WW, Bruggensmith P (1987) Removal of toxic levels of n-acetylprocainamide with continuous arteriovenous hemofiltration or continuous arteriovenous hemodiafiltration. Ann Intern Med 106:550–552PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin, Heidelberg 1991

Authors and Affiliations

  • S. K. Wedel

There are no affiliations available

Personalised recommendations